Tue, October 17, 2023
Mon, October 16, 2023
Sun, October 15, 2023
Fri, October 13, 2023
Thu, October 12, 2023
Wed, October 11, 2023

Allison Bratzel Initiated (ABCL) at Buy and Held Target at $20 on, Oct 13th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-20-on-oct-13th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Allison Bratzel of Piper Sandler, Initiated "AbCellera Biologics Inc." (ABCL) at Buy and Held Target at $20 on, Oct 13th, 2023.

Allison has made no other calls on ABCL in the last 4 months.



There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Allison's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Allison


  • Robert Wasserman of "Benchmark" Maintained at Strong Buy with Decreased Target to $12 on, Thursday, August 31st, 2023
  • Andrea Tan of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $24 on, Friday, August 4th, 2023

Publication Contributing Sources